Trial NCT03386929

View at ClinicalTrials.gov 
Org. Study IDs: WIN001
Secondary IDs: 2017-001455-32

Last trial update was posted on 2023-12-18

MeSH Interventions

Avelumab Axitinib Palbociclib

MeSH Conditions

Carcinoma, Non-Small-Cell Lung Lung Neoplasms

Other Conditions

Non-small Cell Lung Cancer Metastatic Non-small Cell Lung Cancer Stage IIIB

Stopping Reasons

The SPRING trial had to be early terminated at the end of the Phase 1 portion of the study due to the absence of funding necessary for the performance of the Phase 2.

Limitations And Caveats

The trial was early terminated after the end of its Phase 1 due to lack of funding. As a result it was not possible to analyse the objectives of the study.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID